A Wayland, Massachusetts-based leader and executive in the health science industry, Alexander Cherkassky received his MS in bioinformatics from Boston University in 2002. Subsequently, he obtained his MBA from the New York Institute of Technology. As the vice president of Fluidigm Inc, focusing on tissue imaging and mass cytometry, Alexander Cherkassky is versed in various cytometric technologies.
The CyTOF® platform is the most advanced cytometric technology in the world. CyTOF®-powered mass cytometry enables simultaneous evaluation of millions of cells using over 50 different markers. CyTOF® has proven efficacy and applicability in various research areas – including immunology, oncology, and epidemiology.
With the CyTOF® platform, researchers can sort samples through barcoding and work with cells in solid and liquid samples. The data generated from each analysis can be recorded in standard Helios or CyTOF® XT data files. These files are compatible with multiple software, including Maxpar Pathsetter and FCS Express.
Alexander Cherkassky 